Guided Therapeutics (GTHP) Long-Term Debt Repayments (2018 - 2025)
Guided Therapeutics' Long-Term Debt Repayments history spans 8 years, with the latest figure at $187000.0 for Q4 2025.
- On a quarterly basis, Long-Term Debt Repayments fell 6.03% to $187000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $499000.0, a 13.93% increase, with the full-year FY2025 number at $499000.0, up 13.93% from a year prior.
- Long-Term Debt Repayments hit $187000.0 in Q4 2025 for Guided Therapeutics, up from $94000.0 in the prior quarter.
- Over the last five years, Long-Term Debt Repayments for GTHP hit a ceiling of $811000.0 in Q2 2021 and a floor of $41000.0 in Q2 2023.
- Historically, Long-Term Debt Repayments has averaged $180944.4 across 5 years, with a median of $116500.0 in 2024.
- Biggest five-year swings in Long-Term Debt Repayments: crashed 94.7% in 2022 and later skyrocketed 342.22% in 2024.
- Tracing GTHP's Long-Term Debt Repayments over 5 years: stood at $811000.0 in 2021, then tumbled by 90.75% to $75000.0 in 2022, then tumbled by 40.0% to $45000.0 in 2023, then skyrocketed by 342.22% to $199000.0 in 2024, then decreased by 6.03% to $187000.0 in 2025.
- Business Quant data shows Long-Term Debt Repayments for GTHP at $187000.0 in Q4 2025, $94000.0 in Q3 2025, and $71000.0 in Q2 2025.